The Madras High Court held that Section 3c of the Patents Act, 1970 does not exclude engineered non-living substances from patent protection. The ruling clarifies the distinction between discovery and invention for biotechnology patents in India.
Read more about Engineered non-living substances are not excluded under Section 3(c) of the Patents Act, 1970.Tag: Indian Patent Cases
Divisional Patent Filing, Patent Claim Amendments, Assessment of Damages, and DUS test for PV Protection
This post reviews significant Indian judgments on divisional patent filings, claim amendments, damages, and plant variety protection. It highlights key legal principles regarding patent and plant variety jurisprudence in India.
Read more about Divisional Patent Filing, Patent Claim Amendments, Assessment of Damages, and DUS test for PV ProtectionYou Shouldn’t have filed a Post-Grant Opposition, says Bombay High Court
The Bombay High Court in Safex Chemical India Ltd vs The Controller Of Patents clarified procedures for patent oppositions. The Court dismissed Safex’s writ, emphasising adherence to the statutory process under Indian patent law.
Read more about You Shouldn’t have filed a Post-Grant Opposition, says Bombay High CourtLatest Patent Cases in 2022 – Part 1
This post analyses recent Indian patent cases from 2022, focusing on notable court decisions such as MSN Laboratories v. Novartis Ag. It provides legal insights into patent infringement and injunctions in the pharmaceutical sector.
Read more about Latest Patent Cases in 2022 – Part 1Temporary Injunction – F. Hoffmann-LA Roche Vs. Cipla
The Court refused a temporary injunction in the Roche vs Cipla patent dispute, highlighting non-disclosure, validity challenges, and public interest considerations. This analysis discusses the legal principles applied and the balance between patent rights and access to essential medicines.
Read more about Temporary Injunction – F. Hoffmann-LA Roche Vs. Cipla